RAB27A, member RAS oncogene family
Symbol RAB27A
Entrez 5873
HUGO 9766
OMIM 603868
RefSeq NM_004580
UniProt P51159
Other data
Locus Chr. 15 q21
RAB27B, member RAS oncogene family
Symbol RAB27B
Entrez 5874
HUGO 9767
OMIM 603869
RefSeq NM_004163
UniProt O00194
Other data
Locus Chr. 18 q21.2

Rab27 is a member of the Rab subfamily of GTPases. Rab27 is post translationally modified by the addition of two geranylgeranyl groups on the two C-terminal cysteines.


Mutations that prevent the expression of Rab27 ('knock out' mutations) cause the hypopigmentation and immunodefficiency disorder known as type II Griscelli syndrome, while a decrease in Rab27 prenylation is thought to be involved in choroideremia.

The symptoms of type II Griscelli syndrome have shown that Rab27 is involved in melanosome transport in melanocytes and in cytotoxic killing activity in cytotoxic T lymphoblasts. In melanocytes Rab27 binds the melanosome. The melanosome is transported along the microtubule. Rab27 then recruits Slac2A and myosin Va, these enzymes are essential for the transfer of the melanosomes from the microtubules to actin filaments. The melanosomes can now continue on their path towards the cell periphery. If either Rab27, Slac2A or myosin Va are absent then the melansomes remain in the perinuclear region of the cell. This disruption in pigmentation results in the hypopigmentation seen in the silvery hair colour of patients with Griscelli syndrome.

This article is issued from Wikipedia - version of the 1/27/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.